Mivocabtagene Autoleucel CD19 Chimeric Antigen Receptor T-Cell Therapy in Stiff Person Syndrome: A Nonrandomized Clinical Trial. Piquet AL, Zekeridou A, Gergis U, Gutman J, Kenderian SS, Lowe M, Eggmann S, McKeon A, Pittock SJ, Rakocevic G, et al. JAMA Neurol. 2026 Nov 09. PMID: 43002394. Abstract CommentRecommendBookmarkWatch